Guggenheim Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-14,558
| Closed | -$548K | – | 2275 |
|
|
2021
Q1 | $548K | Buy |
+14,558
| New | +$548K | ﹤0.01% | 1671 |
|
|
2018
Q1 | – | Sell |
-58,501
| Closed | -$1.28M | – | 2827 |
|
|
2017
Q4 | $1.28M | Sell |
58,501
-10,135
| -15% | -$222K | ﹤0.01% | 1940 |
|
|
2017
Q3 | $2.81M | Sell |
68,636
-1,007
| -1% | -$41.2K | 0.01% | 1425 |
|
|
2017
Q2 | $2.1M | Buy |
69,643
+12,234
| +21% | +$368K | 0.01% | 1593 |
|
|
2017
Q1 | $2.08M | Buy |
57,409
+8,471
| +17% | +$306K | 0.01% | 1638 |
|
|
2016
Q4 | $2.45M | Sell |
48,938
-3,739
| -7% | -$187K | 0.01% | 1519 |
|
|
2016
Q3 | $2.77M | Sell |
52,677
-5,522
| -9% | -$290K | 0.01% | 1393 |
|
|
2016
Q2 | $2.41M | Buy |
+58,199
| New | +$2.41M | 0.01% | 1447 |
|